News
FDA Commissioner Scott Gottlieb releases statement on Advancing Beneficial Animal Biotechnology Product Development
This week, the Commissioner, has highlighted the department’s ongoing implementation of its risk-based regulation of the safety and effectiveness of heritable intentional genomic alterations in animals.
